This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Anaissie, E. J. Articles by Rinaldi, M. G. Search for Related Content PubMed PubMed Citation Articles by Anaissie, E. J. Articles by Rinaldi, M. G.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, Oct 1996, 2387-2391, Vol 40, No. 10
Copyright © 1996 by the American Society for Microbiology. All rights reserved.

Microdilution antifungal susceptibility testing of Candida albicans and Cryptococcus neoformans with and without agitation: an eight-center collaborative study

EJ Anaissie, VL Paetznick, LG Ensign, A Espinel-Ingroff, JN Galgiani, CA Hitchcock, M LaRocco, T Patterson, MA Pfaller, JH Rex and MG Rinaldi
Infectious Disease Section, University of Texas M. D. Anderson Cancer Center, Houston 77030, USA.

The growth patterns observed in the trailing wells when fluconazole is being tested may give rise to readings that suggest resistance or increased MICs for known susceptible strains. We conducted a multicenter study to evaluate the intralaboratory and interlaboratory reproducibilities of a method that uses agitation to disperse these types of growth. Ten strains of Candida albicans and five strains of Cryptococcus neoformans were tested against fluconazole, flucytosine, and amphotericin B by using a microdilution adaptation of the proposed reference method of the National Committee for Clinical Laboratory Standards for yeasts (M27-T). The endpoint criterion used before agitation was consistent with the M27-T recommendation, while a criterion of 50% or more reduction of growth compared with the control was used after agitation. The results of this study showed that use of agitation and the modified endpoint criterion both improved intralaboratory and inter-laboratory agreement and increased the frequency of interpretable MICs. The MICs obtained by this method were comparable to those obtained by the broth macrodilution M27-T method. Like M27-T, this method was not able to definitely distinguish amphotericin B-susceptible from -resistant strains, although the MICs for the resistant strains were consistently higher than those for the susceptible ones. The findings imply that agitation should be seriously considered when antifungal agents, particularly fluconazole, are tested in a microdilution format.

This article has been cited by other articles:

• Liao, R. S., Rennie, R. P., Talbot, J. A. (2002). Comparative Evaluation of a New Fluorescent Carboxyfluorescein Diacetate-Modified Microdilution Method for Antifungal Susceptibility Testing of Candida albicans Isolates. Antimicrob. Agents Chemother. 46: 3236-3242 [Abstract] [Full Text]  
• Arikan, S., Ostrosky-Zeichner, L., Lozano-Chiu, M., Paetznick, V., Gordon, D., Wallace, T., Rex, J. H. (2002). In Vitro Activity of Nystatin Compared with Those of Liposomal Nystatin, Amphotericin B, and Fluconazole against Clinical Candida Isolates. J. Clin. Microbiol. 40: 1406-1412 [Abstract] [Full Text]  
• Rex, J. H., Pfaller, M. A., Walsh, T. J., Chaturvedi, V., Espinel-Ingroff, A., Ghannoum, M. A., Gosey, L. L., Odds, F. C., Rinaldi, M. G., Sheehan, D. J., Warnock, D. W. (2001). Antifungal Susceptibility Testing: Practical Aspects and Current Challenges. Clin. Microbiol. Rev. 14: 643-658 [Abstract] [Full Text]  
• Girmenia, C., Tuccinardi, C., Santilli, S., Mondello, F., Monaco, M., Cassone, A., Martino, P. (2000). In vitro activity of fluconazole and voriconazole against isolates of Candida albicans from patients with haematological malignancies. J Antimicrob Chemother 46: 479-484 [Abstract] [Full Text]  
• Llop, C., Pujol, I., Aguilar, C., Sala, J., Riba, D., Guarro, J. (2000). Comparison of Three Methods of Determining MICs for Filamentous Fungi Using Different End Point Criteria and Incubation Periods. Antimicrob. Agents Chemother. 44: 239-242 [Abstract] [Full Text]  
• Lozano-Chiu, M., Arikan, S., Paetznick, V. L., Anaissie, E. J., Rex, J. H. (1999). Optimizing Voriconazole Susceptibility Testing of Candida: Effects of Incubation Time, Endpoint Rule, Species of Candida, and Level of Fluconazole Susceptibility. J. Clin. Microbiol. 37: 2755-2759 [Abstract] [Full Text]  
• Sheehan, D. J., Hitchcock, C. A., Sibley, C. M. (1999). Current and Emerging Azole Antifungal Agents. Clin. Microbiol. Rev. 12: 40-79 [Abstract] [Full Text]  
• Lozano-Chiu, M., Paetznick, V. L., Ghannoum, M. A., Rex, J. H. (1998). Detection of Resistance to Amphotericin B among Cryptococcus neoformans Clinical Isolates: Performances of Three Different Media Assessed by Using E-Test and National Committee for Clinical Laboratory Standards M27-A Methodologies. J. Clin. Microbiol. 36: 2817-2822 [Abstract] [Full Text]  
• Revankar, S., Kirkpatrick, W., McAtee, R., Fothergill, A., Redding, S., Rinaldi, M., Patterson, T. (1998). Interpretation of trailing endpoints in antifungal susceptibility testing by the National Committee for Clinical Laboratory Standards method [In Process Citation]. J. Clin. Microbiol. 36: 153-156 [Abstract] [Full Text]